formic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide

C48H62N6O8 — CID 145184830

IUPACformic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide
SMILESCN(CCCCC=O)C(=O)CCN1CCC2(CC1)CC(Nc1ccccc1-c1ccccc1)C2.CNc1ccc(CNCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1.O=CO
InChIInChI=1S/C29H39N3O2.C18H21N3O4.CH2O2/c1-31(17-8-3-9-21-33)28(34)14-18-32-19-15-29(16-20-32)22-25(23-29)30-27-13-7-6-12-26(27)24-10-4-2-5-11-24;1-19-12-4-2-11(3-5-12)8-20-9-15(23)13-6-7-14(22)17-18(13)25-10-16(24)21-17;2-1-3/h2,4-7,10-13,21,25,30H,3,8-9,14-20,22-23H2,1H3;2-7,15,19-20,22-23H,8-10H2,1H3,(H,21,24);1H,(H,2,3)
InChIKeyTZCKWBAWOGCUCM-UHFFFAOYSA-N
MW851.06 g/mol
LogP6.52
Rot. Bonds17

About formic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide

formic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide (PubChem CID 145184830) has the molecular formula C48H62N6O8 and a molecular weight of 851.06 g/mol. Its IUPAC name is formic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide.

Molecular Properties

Compound Nameformic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide
PubChem CID145184830
Molecular FormulaC48H62N6O8
Molecular Weight851.06 g/mol
Exact Mass850.46
IUPAC Nameformic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide
SMILESCN(CCCCC=O)C(=O)CCN1CCC2(CC1)CC(Nc1ccccc1-c1ccccc1)C2.CNc1ccc(CNCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1.O=CO
InChIInChI=1S/C29H39N3O2.C18H21N3O4.CH2O2/c1-31(17-8-3-9-21-33)28(34)14-18-32-19-15-29(16-20-32)22-25(23-29)30-27-13-7-6-12-26(27)24-10-4-2-5-11-24;1-19-12-4-2-11(3-5-12)8-20-9-15(23)13-6-7-14(22)17-18(13)25-10-16(24)21-17;2-1-3/h2,4-7,10-13,21,25,30H,3,8-9,14-20,22-23H2,1H3;2-7,15,19-20,22-23H,8-10H2,1H3,(H,21,24);1H,(H,2,3)
InChIKeyTZCKWBAWOGCUCM-UHFFFAOYSA-N
XLogP6.52
TPSA192.80 Ų
H-Bond Donors7
H-Bond Acceptors11
Rotatable Bonds17
Heavy Atoms62
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 500851.06
LogP ≤ 56.52
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'catechol', 'substructure': 'N/A'}

Analyze formic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of formic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide?
The IUPAC name of formic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide (CID 145184830) is formic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide.
What is the SMILES notation for formic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide?
The canonical SMILES for formic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide is CN(CCCCC=O)C(=O)CCN1CCC2(CC1)CC(Nc1ccccc1-c1ccccc1)C2.CNc1ccc(CNCC(O)c2ccc(O)c3c2OCC(=O)N3)cc1.O=CO.
What is the InChIKey of formic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide?
The InChIKey is TZCKWBAWOGCUCM-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H39N3O2.C18H21N3O4.CH2O2/c1-31(17-8-3-9-21-33)28(34)14-18-32-19-15-29(16-20-32)22-25(23-29)30-27-13-7-6-12-26(27)24-10-4-2-5-11-24;1-19-12-4-2-11(3-5-12)8-20-9-15(23)13-6-7-14(22)17-18(13)25-10-16(24)21-17;2-1-3/h2,4-7,10-13,21,25,30H,3,8-9,14-20,22-23H2,1H3;2-7,15,19-20,22-23H,8-10H2,1H3,(H,21,24);1H,(H,2,3).
What are the key properties of formic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide?
formic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide has a molecular weight of 851.06 g/mol, XLogP of 6.52, 17 rotatable bonds, 7 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for formic acid;5-hydroxy-8-[1-hydroxy-2-[[4-(methylamino)phenyl]methylamino]ethyl]-4H-1,4-benzoxazin-3-one;N-methyl-N-(5-oxopentyl)-3-[2-(2-phenylanilino)-7-azaspiro[3.5]nonan-7-yl]propanamide is sourced from PubChem (CID 145184830), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).